Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients
NCT ID: NCT05150327
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2021-10-29
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
NCT06498310
Liver Transplant European Study Into the Prevention of Fungal Infection
NCT01058174
Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients
NCT01260974
Evaluation of a Clinical Decision Support System for Fungal Infections
NCT05656157
Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants
NCT00001107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject with a liver transplant in one of the centers participating in the study
* Invasive fungal infection with filamentous fungus between 2007-2021
* Proven or probable infection with filamentous fungi according to EORTC/MSGERC criteria:
* Invasive aspergillosis
* Mucormycosis
* Fusariosis
* Scedosporiosis
* Other infection with filamentous fungus
* Subject or legal representative for minors, who has not expressed, after information, his opposition to the reuse of his data for scientific research purposes.
Exclusion Criteria
* Subject not with a liver transplant
* Subject under guardianship, curatorship or legal protection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François DANION, MD
Role: STUDY_DIRECTOR
Service des Maladies Infectieuses et Tropicales - Hôpitaux Universitaires de Strasbourg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service des Maladies Infectieuses et Tropicales - Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8429
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.